Drug Database
Back to search

Netherlands· NL-b59af47a42a7

Minims Cyclopentolaathydrochloride 10 mg/ml, oogdruppels, oplossing

A cyclopentolate product containing cyclopentolaathydrochloride, registered in Netherlands by Bausch + Lomb Ireland Limited. The same ATC class is registered in 16 of our 19 countries.

ATC S01FA04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMinims Cyclopentolaathydrochloride 10…ATCS01FA04REGISTER NO.NL-b59af47a42a7PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cyclopentolaathydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cyclopentolate is registered in 16 of 19 countries.

Countries holding a registration under ATC S01FA04 (cyclopentolate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search cyclopentolate products by name

Cyclopentolate · ATC S01FA04

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CYCLOPENTOLAATHYDROCHLORIDE
Manufacturer
Bausch + Lomb Ireland Limited
Country
Netherlands (NL)
ATC code
S01FA04
ATC class
Cyclopentolate
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    09359

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for cyclopentolate.

Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cyclopentolate against other medicinesHow interaction checks work

Cyclopentolate · interactions on record

3 records

  • 3 moderate

Most severe, free to view

  • PhenylephrineC01CA06moderate
  • PhysostigmineS01EB05moderate
  • PhysostigmineV03AB19moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyclopentolate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyclopentolate products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Belgium · Cyclogyl, Minims Cyclopentolaathydrochloride Bausch + Lomb Ireland Limited
  • Bulgaria · Цикловижън
  • Cyprus · Cyclogyl
  • Czechia · Cyclopentolate Olikla
  • Germany · Cyclopentolat Alcon, Zyklolat Edo
  • Denmark · Cyclogyl
  • Spain · Colirofta Ciclopléjico
  • Finland · Oftan Syklo
  • France · Skiacol
  • Greece · Cyclogyl
  • Hungary · Humapent
  • Ireland · Minims
  • Iceland · Cyclogyl
  • Italy · Ciclolux, Plegik
  • Lithuania · Cyclogyl
  • Luxembourg · Minims, Minims Cyclopentolate Chlorhydrate Bausch + Lomb Ireland Limited
  • Malta · Minims Cyclopentolate Hydrochloride Bausch + Lomb Ireland
  • Norway · Cyclopentolat Bausch + Lomb Ireland Limited
  • Poland · Cykloftyal
  • Portugal · Cicloplegicedol, Midriodavi
  • Sweden · Cyclogyl, Cyclopentolat Bausch & Lomb
  • Slovakia · Cyclopentolate Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/975c4edc-2592-465d-858a-db747d690e9f
GET /v1/drugs/975c4edc-2592-465d-858a-db747d690e9f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h09359_smpc.pdf",
  "strength": null,
  "atc_label": "Cyclopentolate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg09359",
  "excipients": [
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "CYCLOPENTOLAATHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h09359.pdf",
  "authorised_at": "1982/01/19",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "09359",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about cyclopentolate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console